ANI Pharmaceuticals ANIP EBIT

EBIT at other companies

Amneal Pharmaceuticals, Inc.AMRX

$129.77M+16.5%

ViatrisVTRS

$6.3M-97.3%

AnaptysBio, Inc.ANAB

-$34.64M-25.8%

ALN

Alnylam PharmaceuticalsALNY

$231.44M+1,529%

Eton Pharmaceuticals, Inc.ETON

$2.41M+614%

Aurinia PharmaceuticalsAUPH

$46.34M+131%

FAQ

What is ANI Pharmaceuticals's EBIT?

ANI Pharmaceuticals (ANIP) reported EBIT of $40.46M in Q2 2026.

How has ANI Pharmaceuticals's EBIT changed year-over-year?

ANI Pharmaceuticals's EBIT increased by 191.2% year-over-year, from $13.89M to $40.46M.

What is the long-term trend for ANI Pharmaceuticals's EBIT?

Over 4 years (2021 to 2025), ANI Pharmaceuticals's EBIT has grown at a 29.3% compound annual growth rate (CAGR), from -$39.79M to $111.09M.

What does EBIT mean?

Earnings before interest and taxes — the profit from the business before financing cost and tax. Uses reported operating income where a company reports it; otherwise pre-tax income plus interest expense. Lets companies be compared on earning power independent of capital structure.